News & Views
Michelson Diagnostics Bucks Economic Trend
May 14 2009 Read 1130 Times
Medical imaging firm Michelson Diagnostics Ltd (MDL) reports that it has successfully raised investment for growth in 2009, despite the economic downturn having raised just over £350k from a consortium of investors from the London Business Angels (LBA) network and from the management team. The money will be used to support multi-centre clinical trials of its new hand-held Multi-Beam Optical Coherence Tomography (OCT) imaging probe, and also aid international commercial growth.
“We received tremendous customer interest in our new ‘VivoSight’ Multi-Beam OCT probe, when we demonstrated the working prototype at the BiOS09 show (San Jose) in January”, said Michelson’s CEO, Jon Holmes, “and sales of our EX1301 OCT Microscope have accelerated in the last two quarters”. He added: “We plan to launch VivoSight with UK clinical approvals in May/June this year, and I believe that we will post triple-digit sales growth in 2009”.
MDL received early stage funding of £600k in October 2007, and a further £600k in July 2008, in rounds led by London Seed Capital Ltd with Catapult Venture Managers Ltd and the LBA. It has offices in Kent and the West Midlands and was founded in 2006 by Jon Holmes and four other ex-employees of Sira, the photonics instrumentation company.
MDL’s Chairman, John Knowles, said: “The management team has continued to achieve key milestones on time and on budget, and this has enabled a successful fundraising at a time when money is scarce and without loss of value for existing shareholders. We are now well placed to raise a much larger sum, timed to coincide with the economic recovery and results from clinical trials.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - The Separation and Purification of Glutamine Deri...
View all digital editions
Nov 19 2019 Frankfurt am Main, Germany
Nov 20 2019 Tokyo, Japan
Nov 25 2019 Beijing, China
Dec 05 2019 New Delhi, India
Dec 13 2019 Kathmandu, Nepal